Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.

Vitamin D receptor rs2228570 polymorphism and invasive ovarian carcinoma risk: pooled analysis in five studies within the Ovarian Cancer Association Consortium.
复制标题

DOI:
10.1002/ijc.25403
复制
发表时间:
2011-02-15
影响因子:
6.4
通讯作者:
Goodman, Marc T.
Goodman, Marc T.
中科院分区:
医学1区
文献类型:
--
作者:
Lurie, Galina;Wilkens, Lynne R.;Thompson, Pamela J.;Carney, Michael E.;Palmieri, Rachel T.;Pharoah, Paul D. P.;Song, Honglin;Hogdalls, Estrid;Kjaer, Susanne Kruger;DiCioccio, Richard A.;McGuire, Valerie;Whittemore, Alice S.;Gayther, Simon A.;Gentry-Maharaj, Aleksandra;Menon, Usha;Ramus, Susan J.;Goodman, Marc T.

文献摘要

参考文献

被引文献

相似文献

对1820名非西班牙裔白人患者和3479名对照进行了卵巢癌协会内5项基于人群的病例对照研究,研究了侵袭性卵巢癌风险与维生素D受体(VDR)基因功能多态rs2228570(又名rs10735810;FokI多态)的关系。用非条件Logistic回归估计优势比(OR)和95%可信区间(CI)。在所有研究中,携带罕见T等位基因的女性患卵巢癌的风险比携带CC基因的女性高;每个T等位基因的拷贝与风险增加9%相关(OR=1.09;95%CI:1.01-1.19;p=0.04)。研究之间没有观察到显著的异质性(p=0.37),在从夏威夷研究中排除数据集后,重复研究中rs2228570的风险关联没有变化(OR=1.09;95%CI:1.00-1.19;p=0.06)。在年轻女性(50岁与50岁或50岁以上)中观察到rs2228570与风险有更强的关联(p=0.04)。在所有研究中,年轻女性每拷贝T等位基因的风险增加24%(OR=1.24;95%CI:1.04-1.47;p=0.02)。排除夏威夷数据后,这种相关性在统计学上仍然显著(OR=1.20;95%CI:1.01-1.43;p=0.04)。没有观察到分期(p=0.46)、肿瘤组织学(p=0.98)或诊断到问诊之间的时间(p=0.94)的相关性的异质性。这一合并分析进一步证明VDR rs2228570多态可能影响卵巢癌的易感性。
The association of invasive ovarian carcinoma risk with the functional polymorphism rs2228570 (aka rs10735810; FokI polymorphism) in the vitamin D receptor (VDR) gene was examined in 1820 white non-Hispanic cases and 3479 controls in a pooled analysis of five population-based case-control studies within the Ovarian Cancer Association Consortium. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using unconditional logistic regression. Carriers of the rare T allele were at increased risk of ovarian carcinoma compared to women with the CC genotype in all studies combined; each copy of the T allele was associated with a modest 9% increased risk (OR=1.09; 95% CI:1.01–1.19; p=0.04). No significant heterogeneity among studies was observed (p=0.37) and, after excluding the dataset from the Hawaii study, the risk association for rs2228570 among replication studies was unchanged (OR=1.09; 95% CI: 1.00–1.19; p=0.06). A stronger association of rs2228570 with risk was observed among younger women (aged < 50 years versus 50 years or older) (p=0.04). In all studies combined, the increased risk per copy of the T allele among younger women was 24% (OR=1.24; 95% CI: 1.04–1.47; p=0.02). This association remained statistically significant after excluding the Hawaii data (OR= 1.20; 95% CI: 1.01–1.43; p=0.04). No heterogeneity of the association was observed by stage (p= 0.46), tumor histology (p=0.98), or time between diagnosis and interview (p=0.94). This pooled analysis provides further evidence that the VDR rs2228570 polymorphism might influence ovarian cancer susceptibility.
DOI: 10.1158/1055-9965.epi-07-0089
发表时间: 2007-06-01
影响因子: 3.8
作者:
Soegaard, Marie;Jensen, Allan;Kjaer, Susanne K.
通讯作者: Kjaer, Susanne K.
DOI: 10.1093/aje/kwk069
发表时间: 2007-04-01
影响因子: 5
作者:
Park, Song-Yi;Murphy, Suzanne P.;Kolonel, Laurence N.
通讯作者: Kolonel, Laurence N.
DOI: 10.1359/jbmr.1998.13.11.1691
发表时间: 1998-11-01
影响因子: 6.2
作者:
Gross, C;Krishnan, AV;Feldman, D
通讯作者: Feldman, D
DOI: 10.1097/00001813-199304000-00012
发表时间: 1993-04-01
期刊: ANTI-CANCER DRUGS
影响因子: 2.3
作者:
SAUNDERS, DE;CHRISTENSEN, C;DEPPE, G
通讯作者: DEPPE, G
DOI: 10.1093/carcin/bgl089
发表时间: 2006-11-01
期刊: CARCINOGENESIS
影响因子: 4.7
作者:
Song, Honglin;Ramus, Susan J.;Gayther, Simon A.
通讯作者: Gayther, Simon A.